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Abstract
Background
Undifferentiated febrile illness (UFI) is one of the most common reasons for people seeking
healthcare in low-income countries. While illness and death due to specific infections such
as malaria are often well-quantified, others are frequently uncounted and their impact under-
appreciated. A number of high consequence infectious diseases, including Ebola virus, are
endemic or epidemic in the Federal Republic of Sudan which has experienced at least 12
UFI outbreaks, frequently associated with haemorrhage and high case fatality rates (CFR),
since 2012. One of these occurred in Darfur in 2015/2016 with 594 cases and 108 deaths
(CFR 18.2%). The aetiology of these outbreaks remains unknown.
Methodology/Principal findings
We report a retrospective cohort study of the 2015/2016 Darfur outbreak, using a subset of
65 of 263 outbreak samples received by the National Public Health Laboratory which met
selection criteria of sufficient sample volume and epidemiological data. Clinical features
included fever (95.8%), bleeding (95.7%), headache (51.6%) and arthralgia (42.2%). No
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epidemiological patterns indicative of person-to-person transmission or health-worker
cases were reported. Samples were tested at the Public Health England Rare and Imported
Pathogens Laboratory using a bespoke panel of likely pathogens including haemorrhagic
fever viruses, arboviruses and Rickettsia, Leptospira and Borrelia spp. Seven (11%) were
positive for Crimean-Congo haemorrhagic fever virus (CCHFV) by real-time reverse tran-
scription PCR. The remaining samples tested negative on all assays.
Conclusions/Significance
CCHFV is an important cause of fever and haemorrhage in Darfur, but not the sole major
source of UFI outbreaks in Sudan. Prospective studies are needed to explore other aetiolo-
gies, including novel pathogens. The presence of CCHFV has critical infection, prevention
and control as well as clinical implications for future response. Our study reinforces the need
to boost surveillance, lab and investigative capacity to underpin effective response, and for
local and international health security.
Author summary
The Federal Republic of Sudan has had at least 12 outbreaks of febrile illness of unknown
cause associated with symptoms of haemorrhage and high case fatality rates since 2012.
Outbreaks without clear diagnosis are concerning, particularly in countries such as Sudan
where a range of high consequence diseases, including viral haemorrhagic fevers, are
endemic or epidemic, and local laboratory capacity is limited. We transferred historical
samples stored in the National Public Health Authority from one of these outbreaks that
occurred in Darfur 2015–2016 to the Public Health England Laboratory at Porton, UK,
and tested them against a wide range of infectious diseases to try to identify the cause, and
to help the Sudanese Federal Ministry of Health to develop and target their limited labora-
tory capacity. We found that Crimean-Congo Haemorrhagic Fever was an important
cause but not the only source of cases in this outbreak. This has implications for preven-
tion and control as well as for treating cases. Our study also highlighted the need for future
studies to explore other possible causes, including new pathogens, and reinforced the
need to boost surveillance, lab and investigative capacity for more timely and complete
outbreak response.
Introduction
Undifferentiated febrile illness (UFI) is one of the most common reasons for people seeking
healthcare in many low-income countries.[1] While illness and death due to some specific
infections such as malaria are often well-quantified, others which can be caused by a wide
range of pathogens, are frequently uncounted and their impact therefore underestimated.[2,3]
At least 12 outbreaks of undifferentiated febrile illness have been reported in the Federal
Republic of Sudan since 2012, frequently associated with haemorrhage and high case fatality
rates, including a cluster in the Darfur region of Sudan in 2015/2016 which resulted in 594
cases and 108 deaths over 27 localities (Table 1). The aetiology of these outbreaks remains
unknown.
CCHFV and undifferentiated febrile illness outbreaks in Sudan
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A range of high consequence infectious diseases (HCID) are endemic or epidemic in Sudan
including Ebola virus, which was identified contemporaneously in Sudan and the Democratic
Republic of Congo in 1976. [19,20] The National Public Health Laboratory (NPHL) of Sudan
intermittently identifies viral haemorrhagic fever (VHF) cases including Rift Valley fever
(RVF) and Crimean-Congo haemorrhagic fever (CCHF). Sudan is also at high risk of yellow
fever virus (YFV) epidemics, the most recent outbreak occurring in 2012/13.[21] Outbreaks of
dengue fever and chikungunya are common, and cases of West Nile fever have been recorded.
(Table A in S1 Text). There have also been outbreaks of undiagnosed fever with haemorrhagic
symptoms in South Sudan, most recently in Aweil State in 2016, and of RVF in Eastern Lakes
State in 2018.
Outbreak investigation in Sudan is the responsibility of the ministries of health of the 18
states, reinforced by the Federal Ministry of Health (FMoH) when cases appear to increase sig-
nificantly or exhibit characteristics of HCID and/or person-to-person transmission. Alerts are
received through 1659 sentinel sites (27% of all health facilities) which transmit reports weekly
or daily depending on the disease. In past outbreaks, epidemiological data have often been
incomplete and laboratory analysis delayed due to the limited capacity of state-level laborato-
ries which necessitates transfer of samples for analysis to the NPHL in Khartoum. Rapid
Table 1. Outbreaks of fever with haemorrhagic symptoms reported by the Federal Ministry of Health and in ProMED-mail, in the Republics of Sudan & South
Sudan, 2012–2017.
SUDAN
Month/Year Location affected Main symptoms /suspected cause Cases Deaths
(%)
Sept 2012 [4] Zalingei, Central
Darfur
Headache, vomiting, fever unkn 7
Oct 2012 [4] Korley, South Darfur Fever 16 6 (37.5)
Dec 2012- Oct 2013
[5–7]
Greater Darfur Several syndromes: yellow skin, vomiting and diarrhoea; face/leg swelling, rash leading to bruising,
mainly children. Considered to be yellow fever
847 171 (20.2)
Jun 2014 [8] Kalma, South Darfur High fever, loss of appetite, headache, pain in chest, vomiting unkn 18
Oct 2014 [9] El Fula, Muglad, West
Kordofan
High fever, bleeding, nosebleed 4 4 (100.0)
Nov 2014 [10] Kalma, South Darfur Fever, headache, high fever, bleeding (nose/mouth) unkn 3
Nov 2014 [11] South Kordofan High fever, vomiting, headache. ?Haemorrhagic fever and/or kala azar—unconfirmed 25 unkn
Nov 2014 [12] Wad Madani, El
Gazeera
Fever, bleeding: suspected haemorrhagic fever 30 19 (63.0)
Aug 2015 –Apr
2016 [13,14]
Greater Darfur Fever, bleeding (98%), joint pain, jaundice. ?Dengue 594 108 (18.2)
Oct 2015—Feb
2016
Kordofan ?Dengue (6 lab +ve), no profuse bleeding 47 4 (8.5)
Oct 2015—Feb
2016
Kassala ?Dengue (4 ELISA IgM +ve) 7 1 (14.3)
Apr–Nov 2017 [15] Tokar, Red Sea State Fever and “haemorrhagic” symptoms 82 unkn
SOUTH SUDAN
2003 [16] Imatong, Equatoria Headache, fever, bloody diarrhoea, nosebleeds 178 11 (6.2)
Sept 2013[17] Pibor, Jonglei Fever, headache, paralysis: rapidly fatal. unkn 15
Dec-2015—May
2016 [18]
Aweil North & West Fever, bleeding, fatigue, headache, vomiting. 33 samples tested externally: 5 positive for o’nyong
‘nyong; 3 for chikungunya, 1 dengue. All negative for viral haemorrhagic fever. ?Susugo
paramyxovirus ?Lujo virus.
55 10 (18.2)
‘?’ denotes postulated cause of outbreak without confirmation or with inadequate confirmed cases to be considered responsible for the outbreak. Grey highlighted row is
the outbreak investigated in this study. Bracketed numbers refer to entries in the reference list.
https://doi.org/10.1371/journal.pntd.0007571.t001
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Response Teams comprising epidemiology, laboratory and clinical staff have been established
in each State and at Federal level to improve the speed and depth of outbreak investigation.
The Darfur outbreak, reported to FMoH on September 21, 2015 and eventually affecting all
5 states in the Darfur region, was initially thought to result from severe dengue complicated by
malaria and other underlying conditions such as sickle cell disease commonly found among
some tribes in Darfur.[22] However, only 24% of the suspect case samples received and tested
by NPHL showed evidence of dengue virus (DENV) IgM antibodies, and no samples were pos-
itive by PCR. Samples tested for viral haemorrhagic fevers at the WHO collaborating labora-
tory in Dakar, Senegal and the Robert Koch Institute in Berlin were also all negative. Limited
in their capacity to test further due to restrictions on reagent importation, the NPHL tested a
small number of samples (30) in-house for CCHFV and found 7 were PCR positive, all from
East Darfur. A further 7 samples were found to have serological evidence of West Nile fever
virus but as neutralisation tests were not available, a cross-reaction could not be ruled out.
Over the next 9 months, 594 cases were reported using the outbreak case definition (Fig 1)
across 27 localities of Darfur, the majority coming from West Darfur and focused on Kereinik,
followed by Al Sareef in North Darfur, and Zalingei in Central Darfur–areas which hosted sub-
stantial numbers of displaced people. Cases peaked in November 2015 and dropped to spo-
radic cases from February until the announced end of the outbreak in May 2016. (Fig 2) Since
then, at least 3 smaller outbreaks of a similar syndrome have occurred in different locations in
Sudan.
The unknown source(s) and ill-defined characteristics of these outbreaks are of significant
concern. To try to identify the outbreak pathogen(s), better characterise the outbreak syn-
drome, inform public health and treatment interventions, and assist development of diagnostic
capacity, we investigated a set of stored samples from the outbreak with a bespoke panel of
molecular and serological assays and epidemiological analysis.
Materials and methods
Ethics statement
Approval for the study was granted by the FMoH Technical Review Board, and the Ethics
Committees of Karary University, Khartoum and the London School of Hygiene & Tropical
Medicine (Ref: 11930). Individual consent was not required as samples were collected for diag-
nostic purposes during the public health response to the outbreak. Permission to export sam-
ples to the UK was given by the FMoH and samples and data were anonymised before transfer.
The NPHL received blood samples from 263 of the 594 cases notified during the outbreak,
from which serum was stored. After matching data held by the FMoH Epidemiology Unit with
Fig 1. Case definition used in the field during the Darfur outbreak.
https://doi.org/10.1371/journal.pntd.0007571.g001
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samples and data stored at the NPHL, we evaluated samples for inclusion in the study using
the following criteria: sufficient sample volume to accommodate multiple tests (>300 μl); suffi-
cient epidemiological data to allow minimum characterisation of the case; specimen not previ-
ously tested by an external laboratory, and not previously tested positive for CCHFV in NPHL.
Sixty-five (65) of the 263 stored samples met the criteria and were transported as frozen serum
to the Rare and Imported Pathogens Laboratory (RIPL), Porton, UK where assays covering a
broad range of likely pathogens were performed (Fig 3). As sample volume was limited, PCR
assays were chosen based on clinical syndrome and geographical location and included hae-
morrhagic fever viruses, arboviruses, arenaviruses, leptospirosis and rickettsiae. Samples that
did not meet the criteria (198) were not transferred and remained stored in NPHL. Sensitivity
analysis was performed to assess if the samples transferred to the UK were representative of
the samples that remained in Sudan.
Laboratory methods
Detailed information on the design and conditions for each assay is available in the Technical
Appendix: Laboratory and Metagenomic Materials and Methods in Supporting Information
(S1 Text)
Molecular analysis. PCRs using nucleic acid extracted from plasma were performed on
all 65 samples in parallel, for pathogens and in the sequence shown in Fig 3, and in accordance
with RIPL clinical protocols. After the detection of CCHF RNA, serological assays for CCHF
IgG and IgM were performed on all 65 samples to investigate if acute cases were present that
had not been identified by PCR and if there was evidence of previous exposure.
Serological analysis. Plasma samples in which CCHFV RNA was detected were trans-
ferred to a containment level (CL) 4 laboratory in PHE Porton and heat-inactivated at 56˚C
for 30 minutes (with intermittent sample-mixing) before transfer to the CL2 laboratory in the
same location for ELISA analysis. Samples in which no CCHFV RNA was detected were
Fig 2. Reported cases and deaths, August 24, 2015—May 9, 2016 by symptom onset (n = 594).
https://doi.org/10.1371/journal.pntd.0007571.g002
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analysed without additional pre-treatment. VectoCrimea-CHF ELISA kits (Vector-Best, Novo-
sibirsk, Russia) were used for detection of CCHFV-specific IgG and IgM. Absorbances were
read at an optical density of 450nm (OD450nm) on a microplate reader (SpectraMax M3,
Molecular Devices, UK) and analysed using SoftMax Pro (version 7.0, Molecular Devices,
UK). The cut-off value was calculated as the average OD450nm of the negative controls supplied
with the kit + 0.2. Samples were considered to be positive if their OD450nm was greater than or
equal to this cut-off value.
Genome sequencing. A metagenomic RNA sequencing protocol and analysis, described
in detail previously, was applied to fresh extracts of the 7 CCHFV positive samples and
sequenced in the RIPL on a MiSeq (Illumina, UK).[23] CCHF-negative samples were also pre-
pared for metagenomic sequencing using residual extracts remaining after PCR as too few had
primary sample available for fresh extract. However, processing of this group was halted after
analysis of 22/58 revealed inadequate RNA quality.
Data analysis. Data cleaning and analysis was carried out at the London School of
Hygiene & Tropical Medicine (LSHTM) in collaboration with the FMoH epidemiology team.
Results are expressed as the median and Inter-Quartile Range (IQR) for continuous variables,
and frequencies and percentages (n (%)) for categorical variables. Associations were tested
Fig 3. Assays and sequence of testing of transferred samples.
https://doi.org/10.1371/journal.pntd.0007571.g003
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using Fisher’s exact test or Chi2 as appropriate. We compared the characteristics of the samples
transferred to RIPL with those that were not transferred for potential bias and assessed the
effect of missing values. Variables without a definitive entry (e.g. yes/no, positive/negative)
were counted as missing data. Significance level was set at<0.05. All analyses were completed
in STATA (StataCorp LLC, USA, V14.2).
Results
Forty-three per cent (263) of the 594 cases notified in the outbreak had samples sent to NPHL.
The majority of those sampled came from West Darfur (40.3%, 104/258), Central Darfur
(23.6%, 61/258), and East Darfur (15.5%, 40/258), with the remainder from North and South
Darfur (55/258) and 5 samples without location data.
The majority of all sampled cases were children or young adults and were either at school
or studying or working in farming or animal husbandry. There were no samples from health-
care workers. The most common symptoms among all sampled cases were fever (95.8%, 252/
263)), bleeding (95.7%, 235/243), mainly epistaxis (57.4%, 140/244) and hematemesis (53.5%,
129/241) headache (51.6%, 128/248) and arthralgia (42.2%, 103/244) (Table 2).
Representativeness of tested samples
Sixty-five (24.7%) of the samples met the criteria for transfer for testing at RIPL. These were
largely representative of the total cases sampled. There were no significant demographic differ-
ences, nor differences in the time from symptom onset to sample-taking, in the assays used by
NPHL on the sample during the outbreak, or in their results or case outcome (Table 2). However,
the transferred samples were associated with significantly less fever (p<0.001) and more bloody
diarrhoea (p = 0.02) than those not transferred. It must be noted that, although a case definition
was established during the outbreak, not all notified cases corresponded to it when analysed.
Case fatality was similar in both transferred and non-transferred samples (6.4%, 3/47 and
8.2%, 16/196 respectively, p = 1.0), but outcome data were missing in 18/65 cases in transferred
group (27.7%) and 2/198 in non-transferred samples (1.01%).
Only 8 cases overall–none of which were among the transferred samples–reported any ani-
mal contact, but over 75% of data for this variable were missing. No other exposure variables
were routinely reported, though early investigators reported seeing no epidemiological pat-
terns, such as family clusters or healthcare worker infections, that might indicate person-to-
person transmission.
Laboratory results
Of the 15 tests performed on the 65 samples transferred to RIPL (Fig 3 & S1 Text), only the
RT-PCR and ELISA for CCHFV produced positive results. Seven (11%) samples were positive
on both RT-PCR and IgG ELISA, including 2 samples which had previously tested negative for
CCHFV at NPHL. Cycle thresholds ranged from 23.90 to 36.02. Six of the 7 were also ELISA
IgM positive. An additional 4 samples were RT-PCR and IgM-negative but positive for
CCHFV IgG antibodies. All other samples tested negative on all assays.
No significant results were initially obtained through the metagenomic sequencing of either
the CCHFV positive or negative samples due to inadequate RNA quality after storage and PCR
work. However, when fresh nucleic acid extracts were made from primary samples for the
CCHFV positive samples, sequencing on an Illumina MiSeq was successful, and confirmed
that sequence reads identifiable as CCHFV were present in all 7 samples. Genome coverage
varied widely between the samples (0–99.5% for the S segment, 0–96.5% for the M and 5.5–
98.5% for the L, at 5x minimum depth) but produced adequate information to characterise the
CCHFV and undifferentiated febrile illness outbreaks in Sudan
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virus. Phylogenetic analysis of the near-complete S-segment of the sample with the highest
quality information (S segment: 99.5%; M segment: 96.5%; L segment: 98.5%), dated 18 Octo-
ber in Table 3: male, 5 years, Ct 23.9), placed it within the Africa 3 S Segment clade, and
Table 2. Sensitivity analysis of characteristics of samples from the Darfur outbreak, 2015–2016 tested in RIPL
(n = 65) and samples not meeting testing criteria (n = 198).
Total outbreak case samples
received by NPHL (N = 263)
Samples remaining in NPHL after
selection criteria applied
% (cases/n—missing data)
Samples meeting criteria & transferred
& tested in RIPL
% (cases/n—missing data)
Sex (Male) 64.1% (127/198) 51.6% (33/64)
Age: median (IQR) (n) 13.5 (7–25) years (198/198) 14.0 (9–25) years (61/65)
Age group (years)
<5 15.7% (31/198) 8.2% (5/61)
5–14 36.4% (72/198) 42.6% (26/61)
15–29 27.3% (54/198) 29.5% (18/61)
30–44 12.1% (24/198) 11.5% (7/61)
45+ 8.6% (17/198) 8.2% (5/61)
Occupation
Child/student 59.2% (109/184) 60.9% (28/46)
Agricultural work 26.6% (49/184) 34.8% 16/46)
Non-agricultural work 6.0% (11/184) 0% (0/46)
Home/unemployed 8.1% (15/184) 4.3% (2/46)
Location
West Darfur 41.4% (82/198) 36.7% (22/60)
Central Darfur 22.7% (45/198) 26.7% (16/60)
East Darfur 17.2% (34/198) 10.0% (6/60)
North Darfur 10.1% (20/198) 18.3% (11/60)
South Darfur 8.6% (17/198) 8.3% (5/60)
Symptoms
Fever� 99.5% (197/198) 84.6% (55/65)
Any bleeding 96.9% (190/196) 95.7% (45/47)
Epistaxis 57.1% (112/196) 58.3% (28/48)
Gum 10.6% 20/189 14.0% (7/50)
Hematemesis 51.3% (97/189) 61.5% (32/52)
Bloody diarrhoea� 10.1% (19/188) 23.4% (11/47)
Joint pain 39.1% (75/192) 53.9% (28/52)
Loss of consciousness 7.4% (14/189) 8.5% (4/47)
Loss of appetite 29.6% (51/192) 40.0% (20/50)
Headache 49.5% (96/194) 59.3% (32/54)
Convulsions 12.2% (23/189) 8.3% (4/48)
Exposure
Contact with animals 14.8% (8/54) No data
Case Fatality 8.2% (16/196) 6.4% (3/47)
Onset to admission median
(IQR) (n)
2 (1–3) days (181/198) 2 (1–3) days (41/65)
Onset to sampling median
(IQR) (n)
4 (2–6) days (189/198) 4 (2–7) days (46/65)
Missing data is indicated in the table by the fluctuating denominator (n). In the onset to admission statistic, 15/17
missing cases among the non-transferred and 5/24 of the cases transferred to RIPL were not admitted.
� Significant difference between the two groups p = > 0.05
https://doi.org/10.1371/journal.pntd.0007571.t002
CCHFV and undifferentiated febrile illness outbreaks in Sudan
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007571 July 10, 2019 8 / 15
showed close homology to the 2009 Sudan strain (HQ378179.1). (Genbank accession nos. S
Segment: MK442893; M Segment: MK442894; L Segment: MK442895). See Fig 4 and S1 Text
for further details.
Serological assays performed by NPHL during the outbreak on some of the study samples
identified evidence of dengue antibodies in 23.2% (13 of 56 tested samples), chikungunya virus
(1/65), hepatitis E virus (1/7) and West Nile virus (1/1). None of these infections were detected
in RIPL testing. The only potential for co-infection seen was malaria. Clinical records at the
time reported that 62.9% of the samples transferred to the UK were malaria-positive, including
three of the cases subsequently shown to be positive for CCHF. Malaria testing was not
repeated in RIPL.
Characteristics of CCHFV positive cases
All 7 CCHFV RT-PCR positive/IgM positive cases were males aged 21 to 30 years, except for a
5-year-old boy who was also the only reported death in the group (CFR 20.0% of the 5 cases
with reported outcome) (Table 3). The fatality was one of three CCHFV cases reported to be
coinfected with malaria. Four of the positive cases were farmers and 2 were of unknown occu-
pation. Three came from East Darfur, 2 from North Darfur and 1 each from South and Central
Darfur. Of the 4 cases who were only CCHFV IgG positive, 1 came from each of North, South
and East Darfur and the origin of the 4th was unknown. Two of the 4 worked in animal
husbandry.
Acute CCHFV positive cases were similar to CCHFV negative cases in most characteristics
and symptoms, including the time from symptom onset to admission to a health facility and to
sample-taking.
The only significant associations with acute CCHFV positivity were male sex (p 0.02) and
origin in the state of East Darfur (p 0.002). The association with location was reinforced when
RIPL-identified CCHFV positive cases were added to those identified during the outbreak by
NPHL: when combined, 23% of all samples originating from East Darfur during the outbreak
(9/40) were CCHFV positive and occurred during a 9-week period (September 28, 2015—Jan-
uary 12, 2016). NPHL-identified CCHFV positives originated from 2 main localities in East
Darfur: RIPL-identified positives occurred in similar areas. Unfortunately, epidemiological
data are not complete enough to investigate possible transmission links. CCHFV positive cases
were less likely to report rectal bleeding than CCHFV negative cases (p 0.04) but half the
CCHFV positive cases had missing data for this symptom.
Discussion
Comprehensive diagnostic evaluation of this set of historical samples has demonstrated that
CCHFV was one important cause, but not the only aetiology, of the large outbreak of undiffer-
entiated febrile illness with haemorrhagic symptoms in Darfur in the 2015–2016. This fact that
CCHFV was not the main cause is reinforced by the absence of CCHFV-positive samples from
West Darfur, the state reporting the majority of cases in the outbreak. The substantial propor-
tion of CCHFV-positive samples from East Darfur might suggest that the virus played a stron-
ger role in the outbreak there, or that it simply represents background transmission in an
endemic area. The 4 cases who were only CCHFV IgG positive most likely represent previous
CCHFV exposure. It is also important to note that we found no evidence of DENV infection
despite several previous outbreaks in the area having been attributed to this pathogen.
CCHFV-specific antibodies have been found in 19.1% of cattle in East Darfur and 21.3% of
camels in Khartoum State, as well as in camels, sheep and goats exported from Sudan.[24,25]
The first human cases of CCHFV in Sudan were confirmed during an outbreak of
CCHFV and undifferentiated febrile illness outbreaks in Sudan
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haemorrhagic fever among healthcare workers in Al Fulah Rural Hospital, Western Kordofan
in 2008 with a CFR of 69.2%.[26] Since then, an average of 12 cases of human CCHFV have
been confirmed by NPHL per year and multiple strains have been identified.[27] However, the
persistent lack of laboratory capacity and supply at central level and complete absence of test-
ing at district level mean that cases are likely to be under-reported.
The CFR of 20.0% among the CCHFV positive cases identified in this outbreak is at the
lower end of the reported range for comparable resource-limited treatment settings. It is lower
than might be expected given the severity of the reported illness[28,29], but similar to mortality
in highly endemic regions such as Kazakhstan and Tajikistan.[30] One explanation may be
that the severely ill and dead were less likely to be sampled, a possibility supported by the
much higher mortality among outbreak cases reported but not sampled (24.1%). The only fatal
case identified was in a 5year-old child with haemorrhage, and reportedly coinfected with
malaria, who was admitted two days after onset of symptoms, who tested negative by PCR at
the NPHL but subsequently positive by PCR and sequencing at RIPL and died 3 days after
admission. While fatal outcome of CCHF in children is thought to be rare it has been reported
from a range of settings.[31–33]
An explanation for the finding of positive CCHFV results in two samples previously tested
‘negative’ at NPHL could be that CT values were borderline, but unfortunately documentation
at that time only reported results as negative or positive. It is also possible that the assays used
(Altona real time PCR and Euroimmune ELISA) could have been at the limit of their validity
as NPHL have had great difficulty in maintaining reagent supply and conditions during the
embargo in Sudan and with frequent power cuts and equipment failure.
The importance of livestock to the Sudanese economy and the risks that CCHFV presents
to healthcare workers and other patients[34], especially in resource-limited healthcare facili-
ties, highlight the urgent need for improved surveillance and faster, more accessible CCHFV
laboratory diagnosis. But while our comprehensive testing clearly highlights the risks and
Fig 4. Maximum-likelihood phylogenetic tree showing relationship distances obtained by comparing CCHFV S
Segment sequences. Previously defined major groups are indicated by branch colour (Asia 1,2 –Purple, Blue; Africa
1,2,3 –Green, Turquoise, Amber; Europe 1,2- Red, Brown).
https://doi.org/10.1371/journal.pntd.0007571.g004
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response requirements for CCHFV and has underlined some important negative results which
excluded other HCIDs and VHFs, it has not solved the conundrum of what caused the major-
ity of cases.
The absence of a diagnosis for the majority of these historical specimens may result from
compromised sample integrity in transportation from the field to the NPHL, or during the
storage period (18–24 months) between sample collection and final laboratory analysis. While
the NPHL’s receipt of samples for almost 50% of reported cases is remarkable given the chal-
lenges in surveillance and outbreak response in these low-resourced and remote settings, the
inherent delays and difficulties with cold chain take their toll on sample condition. It is also
possible that delayed presentation to health facilities could have led to sampling later in the dis-
ease course when opportunity to identify pathogens by PCR is reduced. A further factor diffi-
cult to assess is the impact of genetic variation and primer and/or probe mismatches during
the PCR testing which may have affected opportunity for positive findings. The extent of our
laboratory work and our sample size was also limited by the relatively small amounts of stored
sample available. This combined with the absence of convalescent samples precluded more
detailed serological analysis.
Increasing the capacity to investigate samples on site through the development of innovative
near-patient diagnostic platforms—a priority in the WHO R &D Blueprint for Action to Pre-
vent Epidemics[35]—and/or improving storage and transfer of samples to the reference labora-
tory, will be key to rapid identification of pathogens in future outbreaks. Additional diagnostic
capacity achieved by increasing the range of assays available in the NPHL, collecting a broader
range of field samples (e.g. urine, naso-oropharangeal and stool samples as well as convalescent
samples) and a developing a sequencing capability, will also increase diagnostic yield.
Our interpretation of the syndrome characteristics was limited by missing epidemiological
data. The absence of full case investigation forms (CIF) for 19 of the 65 investigated samples
restricted characterisation of symptoms, occupation and outcomes. Exposures and contact
information were also rarely recorded–an important oversight for outbreak control–and simi-
lar or greater gaps in data were found in the information of the un-transferred cases. Using a
more detailed CIF in future outbreaks, ideally in electronic format to speed interpretation, and
reinforcing the importance of face-to-face interviews with patients, family and community will
help the capture of important data. To assist investigation of future outbreaks, the UK Public
Health Rapid Support Team/FMoH research collaboration has put in place an ethics-approved
prospective study protocol and trained a study team comprising FMoH, NPHL and University
staff ready to deploy.
In conclusion, Sudan is a large country at the crossroads of Africa and the Middle East that
has experienced several outbreaks of HCIDs and regularly has outbreaks of zoonotic infec-
tions. We have shown the presence of CCHFV as an important cause of fever and haemor-
rhage in Darfur which has critical infection prevention and control as well as clinical
implications for future care and response. To fulfil its global obligations under the Interna-
tional Health Regulations (2005), the FMoH needs to maintain and develop robust surveil-
lance, response and laboratory capacity. Support in these areas, and for well-developed
prospective fever studies, could dramatically improve understanding of circulating pathogens
in Sudan and facilitate the rapid recognition and investigation of the next outbreak.
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